Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study
CompletedOBSERVATIONAL
Enrollment
800
Participants
Timeline
Start Date
October 31, 2021
Primary Completion Date
June 30, 2022
Study Completion Date
September 30, 2022
Conditions
Chronic Coronary SyndromeStable Angina
Interventions
OTHER
No intervention
No intervention
Trial Locations (1)
05403-000
InCor Heart Institute, São Paulo
All Listed Sponsors
collaborator
Servier
INDUSTRY
lead
Ministry of Health, Brazil
OTHER_GOV
NCT06464276 - Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study | Biotech Hunter | Biotech Hunter